Antibodies Against Coronavirus
- All
- News
- Videos
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Omicron Generated Antibodies Effective Against All Variants Of Concern: Top Medical Body Study
The latest study conducted by Indian Council of Medical Research (ICMR) shows that antibodies generated by Omicron, a COVID-19 strain, are not only effective against it but also other variants of concern (VOCs) including Delta.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
T-Cells - The Unsung Heroes In The Fight Against Omicron
An unsung arm of the immune system appears to protect against severe disease with the omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn't engulfed hospitals so far.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Antibodies Aren't The Only Defence Against Omicron. Here's Why
In the fight against the coronavirus, one key component of the human immune system has hogged the limelight: antibodies.
-
J&J Shot Loses Antibody Protection Against Omicron In Study
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
-
73% Population Of Odisha Has COVID-19 Antibodies: Sero-Survey
At least 73 per cent of Odisha's population and over 93 per cent of health workers have developed antibodies against SARS-CoV2, according to a recent sero-survey conducted by Indian Council of Medical Research (ICMR).
-
Delhi Begins 7th Serological Survey To Detect Covid Antibodies
The seventh round of the serological prevelance survey that seeks to find presence of antibodies against COVID-19 began in New Delhi on Friday amid lower number of coronavirus cases being reported in the city for the past several weeks.
-
95% J&K Cops Have Covid Antibodies, Surprise Results For Children: Study
Police personnel in Jammu and Kashmir have the highest level of antibodies against COVID-19 compared to the general population in the valley, says a study by the Government Medical College in Srinagar.
-
Covid Antibodies Wane Over Time, But Immune System Has A Backup Plan
Antibodies against the coronavirus wane over time, but the immune system has a backup plan that doesn't rely on boosters, according to a study by scientists at the University of Pennsylvania, where technology for mRNA vaccines was developed.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Omicron Generated Antibodies Effective Against All Variants Of Concern: Top Medical Body Study
The latest study conducted by Indian Council of Medical Research (ICMR) shows that antibodies generated by Omicron, a COVID-19 strain, are not only effective against it but also other variants of concern (VOCs) including Delta.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
T-Cells - The Unsung Heroes In The Fight Against Omicron
An unsung arm of the immune system appears to protect against severe disease with the omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn't engulfed hospitals so far.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Antibodies Aren't The Only Defence Against Omicron. Here's Why
In the fight against the coronavirus, one key component of the human immune system has hogged the limelight: antibodies.
-
J&J Shot Loses Antibody Protection Against Omicron In Study
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
-
73% Population Of Odisha Has COVID-19 Antibodies: Sero-Survey
At least 73 per cent of Odisha's population and over 93 per cent of health workers have developed antibodies against SARS-CoV2, according to a recent sero-survey conducted by Indian Council of Medical Research (ICMR).
-
Delhi Begins 7th Serological Survey To Detect Covid Antibodies
The seventh round of the serological prevelance survey that seeks to find presence of antibodies against COVID-19 began in New Delhi on Friday amid lower number of coronavirus cases being reported in the city for the past several weeks.
-
95% J&K Cops Have Covid Antibodies, Surprise Results For Children: Study
Police personnel in Jammu and Kashmir have the highest level of antibodies against COVID-19 compared to the general population in the valley, says a study by the Government Medical College in Srinagar.
-
Covid Antibodies Wane Over Time, But Immune System Has A Backup Plan
Antibodies against the coronavirus wane over time, but the immune system has a backup plan that doesn't rely on boosters, according to a study by scientists at the University of Pennsylvania, where technology for mRNA vaccines was developed.
